Catalyst
Slingshot members are tracking this event:
Cynapsus Receives FDA Fast Track Designation for APL-130277 for the Treatment of OFF Episodes in Patients with Parkinson’s Disease
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CYNA |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 29, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Apl-130277, Fast Track Designation, Off Episodes Of Parkinson's Disease
